Targeted Oncology
Impact Factor & Key Scientometrics

I. Basic Journal Info

Country

Germany

Journal ISSN: 17762596, 1776260X

Publisher: Springer Verlag

History: 2006-ongoing

Journal Hompage: Link

How to Get Published:

Research Categories

Scope/Description:

Despite the major efforts made in oncology over the past ten years, only relatively modest improvements have been made in the conventional treatment of cancer. Recently, a better understanding of molecular pathways has provided pathologists with clues to the parthenogenesis of the disease and multiple targets for new strategies. New treatments, monoclonal antibodies or small molecules, have emerged targeting these pathways and inhibiting tumor growth and progression. These "mabs" and "nibs" constitute a new language with its own grammar that oncologists have to learn. Significant work remains in controlling theses processes and understanding these new compounds.